Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone (Q40440): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Transtornos decorrentes do uso de estimulantes, incluindo anfetaminas, metanfetamina ou metcatinona são caracterizados pelo padrão e pelas consequências do uso dessas substâncias. Há uma ampla gama de psicoestimulantes na natureza ou produzidos sinteticamente diferentes da cocaína. As mais numerosas desse grupo são substâncias do tipo anfetamina, incluindo a metanfetamina. Estimulantes prescritos, incluindo a dexanfetamina são indicados para um número limitado de condições, como o transtorno de déficit de atenção e hiperatividade. A metcatinona, conhecida em muitos países como efedrona, é um estimulante sintético potente que é um análogo estrutural da metanfetamina e está relacionada à catinona. Todas essas drogas têm primariamente propriedades psicoestimulantes, e são também vasoconstritoras em graus variáveis. Elas induzem euforia e hiperatividade, como podem ser observadas na intoxicação por estimulantes. Têm propriedades geradoras de dependência potentes, o que pode levar ao diagnóstico de dependência de estimulantes e abstinência de estimulantes após a cessação do uso. Vários transtornos mentais induzidos por estimulantes são descritos.
@@ description / en / description / en @@
+Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone are characterised by the pattern and consequences of use of these substances. There is a wide array of naturally occurring and synthetically produced psychostimulants other than cocaine. The most numerous of this group are the amphetamine-type substances, including methamphetamine. Prescribed stimulants including dexamphetamine are indicated for a limited number of conditions such as for Attention Deficit Hyperactivity Disorder. Methcathinone, known in many countries as ephedrone, is a synthetic potent stimulant that is a structural analogue of methamphetamine and is related to cathinone. All these drugs have primarily psychostimulant properties and are also vasoconstrictors to a varying degree. They induce euphoria and hyperactivity as may be seen in Stimulant Intoxication. They have potent dependence-producing properties, which may lead to the diagnosis of Stimulant Dependence and Stimulant Withdrawal following the cessation of use. Several Stimulant-Induced Mental Disorders are described.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1016273204
@@ Property / Canonical URI: https://id.who.int/icd/entity/1016273204 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:6C46
@@ Property / CURIE: CID11:6C46 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-6C46
@@ Property / Canary Token: dki-india-6C46 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F15.9
@@ Property / Linked ICD 10: F15.9 / rank @@
+Normal rank

Latest revision as of 06:15, 13 August 2026

Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone are characterised by the pattern and consequences of use of these substances. There is a wide array of naturally occurring and synthetically produced psychostimulants other than cocaine. The most numerous of this group are the amphetamine-type substances, including methamphetamine. Prescribed stimulants including dexamphetamine are indicated for a limited number of conditions such as for Attention Deficit Hyperactivity Disorder. Methcathinone, known in many countries as ephedrone, is a synthetic potent stimulant that is a structural analogue of methamphetamine and is related to cathinone. All these drugs have primarily psychostimulant properties and are also vasoconstrictors to a varying degree. They induce euphoria and hyperactivity as may be seen in Stimulant Intoxication. They have potent dependence-producing properties, which may lead to the diagnosis of Stimulant Dependence and Stimulant Withdrawal following the cessation of use. Several Stimulant-Induced Mental Disorders are described.

Language	Label	Description	Also known as
default for all languages	6C46
English	Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone	Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone are characterised by the pattern and consequences of use of these substances. There is a wide array of naturally occurring and synthetically produced psychostimulants other than cocaine. The most numerous of this group are the amphetamine-type substances, including methamphetamine. Prescribed stimulants including dexamphetamine are indicated for a limited number of conditions such as for Attention Deficit Hyperactivity Disorder. Methcathinone, known in many countries as ephedrone, is a synthetic potent stimulant that is a structural analogue of methamphetamine and is related to cathinone. All these drugs have primarily psychostimulant properties and are also vasoconstrictors to a varying degree. They induce euphoria and hyperactivity as may be seen in Stimulant Intoxication. They have potent dependence-producing properties, which may lead to the diagnosis of Stimulant Dependence and Stimulant Withdrawal following the cessation of use. Several Stimulant-Induced Mental Disorders are described.